Corcept Therapeutics Inc financial data

Symbol
CORT on Nasdaq
Industry
Pharmaceutical Preparations
Location
101 Redwood Shores Parkway, Redwood City, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 461 % -28.6%
Quick Ratio 7.25 % -15.3%
Debt-to-equity 22.4 % +29.8%
Return On Equity 23.9 % +21.4%
Return On Assets 19.5 % +16.3%
Operating Margin 22.5 % -2.73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104M shares +1.9%
Common Stock, Shares, Outstanding 103M shares -4.11%
Entity Public Float 1.83B USD -11.2%
Common Stock, Value, Issued 134K USD +1.52%
Weighted Average Number of Shares Outstanding, Basic 103M shares +1.13%
Weighted Average Number of Shares Outstanding, Diluted 111M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 570M USD +33%
Research and Development Expense 217M USD +41.1%
Costs and Expenses 442M USD +34.1%
Operating Income (Loss) 128M USD +29.4%
Nonoperating Income (Expense) 21.8M USD +123%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 150M USD +37.9%
Income Tax Expense (Benefit) 23.8M USD +69.7%
Net Income (Loss) Attributable to Parent 126M USD +33.2%
Earnings Per Share, Basic 1.21 USD/shares +36%
Earnings Per Share, Diluted 1.12 USD/shares +36.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 129M USD -25.4%
Marketable Securities, Current 345M USD +80.5%
Accounts Receivable, after Allowance for Credit Loss, Current 53.8M USD +65.4%
Inventory, Net 8.35M USD +20.8%
Other Assets, Current 9.13M USD
Assets, Current 561M USD +29.6%
Deferred Income Tax Assets, Net 112M USD +43%
Property, Plant and Equipment, Net 1.47M USD +256%
Operating Lease, Right-of-Use Asset 5.68M USD +2319%
Other Assets, Noncurrent 6.94M USD +57.2%
Assets 715M USD +36.2%
Accounts Payable, Current 19.5M USD +144%
Employee-related Liabilities, Current 25.5M USD +64.1%
Accrued Liabilities, Current 59.3M USD +13.6%
Liabilities, Current 101M USD +8.27%
Accrued Income Taxes, Noncurrent 11.9M USD +19.9%
Operating Lease, Liability, Noncurrent 5.63M USD
Liabilities 118M USD +14.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 84K USD +86.7%
Retained Earnings (Accumulated Deficit) 466M USD +37.1%
Stockholders' Equity Attributable to Parent 596M USD +41.4%
Liabilities and Equity 715M USD +36.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 23.8M USD -8.48%
Net Cash Provided by (Used in) Financing Activities -543K USD -400%
Net Cash Provided by (Used in) Investing Activities -9.01M USD -104%
Common Stock, Shares Authorized 280M shares 0%
Common Stock, Shares, Issued 134M shares +2.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.2M USD -93.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 129M USD -25.4%
Deferred Tax Assets, Valuation Allowance 15.9M USD +7.47%
Deferred Tax Assets, Gross 107M USD +39.2%
Operating Lease, Liability 5.67M USD +1809%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 126M USD +30.2%
Lessee, Operating Lease, Liability, to be Paid 8.73M USD +2717%
Property, Plant and Equipment, Gross 4.48M USD +6.85%
Operating Lease, Liability, Current 44K USD -85.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.55M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.38M USD +792%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +12.5%
Deferred Income Tax Expense (Benefit) -7.16M USD -6.48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.08M USD +15923%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.6M USD
Deferred Tax Assets, Operating Loss Carryforwards 3.94M USD -19.3%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.65M USD
Operating Lease, Payments 2.59M USD +12.1%
Additional Paid in Capital 739M USD +11.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 52K USD -56.3%
Depreciation, Depletion and Amortization 68K USD -60.5%
Deferred Tax Assets, Net of Valuation Allowance 90.6M USD +47.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%